Xiao-Liang Wang Selected Research

Infections

1/2023	Interferon-induced transmembrane protein 3 (IFITM3) limits lethality of SARS-CoV-2 in mice.
6/2015	The Relationship Between Serum Interleukin-6 and the Recurrence of Hepatitis B Virus Related Hepatocellular Carcinoma after Curative Resection.
6/2014	siRNA against KIR3DL1 as a potential gene therapeutic agent in controlling HIV-1 infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiao-Liang Wang Research Topics

Disease

15	Pain (Aches) 04/2024 - 07/2014
13	Neoplasms (Cancer) 04/2023 - 03/2008
10	Hypersensitivity (Allergy) 01/2022 - 07/2014
10	Alzheimer Disease (Alzheimer's Disease) 12/2018 - 03/2002
7	Ischemia 09/2015 - 06/2006
7	Brain Ischemia (Cerebral Ischemia) 03/2012 - 10/2002
6	Neuralgia (Stump Neuralgia) 04/2024 - 12/2014
6	Inflammation (Inflammations) 01/2023 - 01/2016
6	Neuroinflammatory Diseases 01/2023 - 10/2016
4	Cognitive Dysfunction 08/2022 - 01/2005
4	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 03/2008
4	Neuroblastoma 01/2018 - 01/2014
4	Myocardial Ischemia (Ischemic Heart Diseases) 01/2018 - 07/2007
4	Hypoxia (Hypoxemia) 01/2017 - 08/2010
4	Hyperalgesia 01/2017 - 03/2016
4	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 12/2016 - 10/2010
4	Stroke (Strokes) 01/2016 - 06/2006
3	Infections 01/2023 - 06/2014
3	Brain Injuries (Brain Injury) 01/2023 - 12/2014
3	Brain Edema (Cerebral Edema) 01/2023 - 10/2016
3	Ischemic Stroke 02/2018 - 07/2014
3	Melanoma (Melanoma, Malignant) 07/2017 - 01/2012
3	Myocardial Infarction 12/2015 - 04/2011
3	Infarction (Infarctions) 07/2012 - 06/2006
2	Epilepsy (Aura) 10/2023 - 09/2019
2	Traumatic Brain Injuries (Traumatic Brain Injury) 11/2022 - 01/2022
2	Neoplasm Metastasis (Metastasis) 12/2020 - 07/2014
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2018 - 01/2014
2	Parkinson Disease (Parkinson's Disease) 06/2017 - 05/2015
2	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2017 - 01/2016
2	Chronic Pain 01/2017 - 01/2017
2	Hepatocellular Carcinoma (Hepatoma) 06/2015 - 01/2012
2	Memory Disorders (Memory Loss) 07/2014 - 01/2005
2	Colonic Neoplasms (Colon Cancer) 07/2014 - 06/2012
2	Reperfusion Injury 07/2012 - 08/2010
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 09/2006 - 02/2005
1	Prediabetic State (Prediabetes) 04/2024
1	Seizures (Absence Seizure) 10/2023
1	Stomach Neoplasms (Stomach Cancer) 04/2023
1	Cerebral Hemorrhage 01/2023
1	Glioma (Gliomas) 12/2022

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 12/2022 - 01/2006
10	Bee Venoms (Bee Venom)IBA 01/2021 - 07/2014
7	Neuroprotective AgentsIBA 01/2022 - 01/2014
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2012
4	Small Interfering RNA (siRNA)IBA 01/2022 - 06/2014
4	Analgesics (Analgesic Drugs)IBA 01/2021 - 03/2016
4	Glutamic Acid (Glutamate)FDA Link 09/2019 - 05/2006
4	2-(1-hydroxypentyl)-benzoateIBA 02/2018 - 06/2006
4	3-n-butylphthalide (butylphthalide)IBA 02/2018 - 08/2003
4	PotassiumIBA 02/2018 - 01/2005
3	AntioxidantsIBA 01/2022 - 12/2014
3	plerixafor FDA Link 01/2022 - 01/2017
3	Freund's AdjuvantIBA 01/2022 - 01/2017
3	Amyloid (Amyloid Fibrils)IBA 01/2018 - 01/2014
3	Caspase 3 (Caspase-3)IBA 07/2012 - 08/2003
3	Protein Isoforms (Isoforms)IBA 06/2012 - 10/2002
3	Potassium Channels (Potassium Channel)IBA 11/2006 - 03/2002
2	Collagenases (Collagenase)FDA Link 01/2023 - 12/2014
2	InterferonsIBA 01/2023 - 12/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 03/2008
2	Guanosine Triphosphate (GTP)IBA 01/2021 - 03/2016
2	Therapeutic UsesIBA 09/2019 - 05/2006
2	ProdrugsIBA 02/2018 - 04/2017
2	Cholinergic Agents (Cholinergics)IBA 01/2018 - 01/2005
2	squamosamideIBA 06/2017 - 05/2015
2	mocetinostatIBA 01/2017 - 10/2015
2	Gabapentin (Neurontin)FDA LinkGeneric 01/2017 - 12/2014
2	Chemokine CXCL12IBA 01/2017 - 01/2017
2	p38 Mitogen-Activated Protein KinasesIBA 03/2016 - 08/2010
2	ElementsIBA 01/2016 - 12/2014
2	Interleukin-6 (Interleukin 6)IBA 06/2015 - 01/2012
2	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2014 - 11/2012
2	Antineoplastic Agents (Antineoplastics)IBA 11/2012 - 10/2011
2	Creatine Kinase (Creatine Phosphokinase)IBA 07/2012 - 01/2010
2	Messenger RNA (mRNA)IBA 02/2005 - 01/2005
2	Galantamine (Galanthamine)FDA LinkGeneric 11/2004 - 01/2003
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 11/2004 - 01/2003
1	phenyl di-n-pentylphosphinateIBA 04/2024
1	sortilinIBA 04/2024
1	ProteomeIBA 10/2023
1	CalcineurinIBA 10/2023
1	tutinIBA 10/2023
1	Anesthetics (Anesthetic Agents)IBA 04/2023
1	Dexmedetomidine FDA Link 04/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Viral AntigensIBA 01/2023
1	NAD (NADH)IBA 01/2023
1	Sirtuin 3IBA 01/2023
1	P7C3-A20IBA 01/2023
1	Temozolomide (Temodar)FDA LinkGeneric 12/2022
1	Adenosine (Adenocard)FDA LinkGeneric 08/2022
1	rhodiolosideIBA 08/2022
1	Protein Kinases (Protein Kinase)IBA 08/2022
1	PhytochemicalsIBA 08/2022

Therapy/Procedure

5	Therapeutics 01/2023 - 01/2003
3	Drug Therapy (Chemotherapy) 12/2022 - 12/2020
2	Injections 01/2020 - 01/2017
1	Intravenous Administration 11/2022
1	Orthopedic Procedures 08/2022